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Abstract
In addition to life expectancy, the length of time a person can expect to remain free of health-related functional impairments 
is becoming increasingly important both for the individuals concerned and for society at large. The indicator healthy life 
years used for this purpose is a key figure for mapping mortality and morbidity. Diabetes is one of the most common 
chronic diseases and can be associated with health-related functional impairments. In 2014, women and men with 
diabetes could expect to have significantly fewer healthy life years than people without diabetes; this particularly applies 
to younger and middle-aged groups. Among 30- to 34-year-olds, for example, women and men with diabetes could expect 
eleven and twelve fewer healthy life years respectively than people without diabetes. These differences narrow with 
increasing age. Ensuring that people with and without diabetes have a similar length of lifetime free of health impairments 
is an important task for public health.
  DIABETES · HEALTH IMPAIRMENTS · HEALTHY LIFE YEARS · BURDEN OF DISEASE · DIABETES SURVEILLANCE
Introduction
Diabetes mellitus is one of the most common chronic dis-
eases and its prevalence is increasing throughout the world 
[1]. Diabetes and its often serious comorbidities and sec-
ondary diseases [2], which both are associated with increased 
mortality [3], require lifelong medical treatment and care. 
In the past few decades, improvements in health care have 
contributed to lower mortality among people with diabetes 
[4, 5] and in turn, to an increasing life expectancy [6, 7]. 
Nevertheless, people with diabetes still have a lower life 
expectancy than people without diabetes [6, 8].
The positive developments in life expectancy in Ger-
many have also contributed to an increase in the number 
of years spent with diabetes [7] and in a higher prevalence 
of health-related functional impairments [9]. These 
impairments can result from the comorbidities and sec-
ondary diseases associated with diabetes which are often 
serious [10]. Although people with diabetes now live 
longer than in previous decades, they also have health 
problems for longer periods of their life. Increasing life 
expectancy is making the length of time spent without 
health-related impairments more important at both an 
individual and societal level. Health impairments primar-
ily involve difficulties in performing everyday activities 
(e.g. getting dressed, washing or moving, eating and 
drinking and taking medication). Considerable impair-
ments here contribute to a significantly reduced health- 
related quality of life [11].
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The European Statistical Office (Eurostat) has defined 
the “Healthy Life Years” (HLY) indicator as a European 
structural indicator and as a key figure in studying mortal-
ity and morbidity [12]. A central goal for public health in 
dealing with diabetes, therefore, is ensuring that people 
with diabetes have a similar number of healthy life years 
than people without diabetes.
Data on healthy life years among younger and mid-
dle-aged people with diabetes have not been available for 
Germany so far. This gap could be closed within the frame-
work of the diabetes surveillance which has been estab-
lished at the Robert Koch Institute since 2015. The aim of 
this article is to compare the figures for healthy life years 
for people with and without diabetes over a broad age spec-
trum and for both sexes.
Indicator
The indicator “Healthy Life Years” is defined here as the 
number of years of life that a person with diabetes can 
expect to have without health-related functional impair-
ments compared to people without diabetes. For the cal-
culation of this indicator, the prevalences of known dia-
betes and of health-related functional impairments are 
taken from the German Health Update (GEDA) 2009, 
2010 and 2012 (n=52,112), nationwide telephone health 
surveys carried out by the Robert Koch Institute. Mortal-
ity rates among the general population in 2014, which are 
also used for the calculation, were provided by the Fed-
eral Statistical Office (full survey). The 2014 relative dia-
betes-related mortality risks are based on health care data 
from all statutory health insurers (provided in accordance 
with Germany’s Data Transparency Ordinance, DaTraV, 
n=47.3 million, population aged 30 years or above). The 
figures set out in the following are for people aged 30 
years or above.
Information about the prevalence of known diabetes 
was assessed in the GEDA surveys using the question, 
‘Have you ever been diagnosed with diabetes by a doctor?’; 
known diabetes is assumed when respondents answer, 
‘Yes’. Data on the prevalence of health impairments is gath-
ered using the question, ‘To what extent do you face per-
manent restrictions to your daily activities by illness? By 
permanent we mean for at least six months’; a health 
impairment is assumed when respondents answer ‘severely 
limited’. The other possible answers ‘limited but not 
severely’ and ‘not limited’ form the complementary group. 
Calculations of the prevalence of diabetes and health 
impairments were undertaken using summarised data from 
three GEDA surveys (2009–2012). Weighting factors were 
used to correct the sample for different selection probabil-
ities and for deviations from the population structure (as 
of 31 December 2011) with regard to sex, age, education 
and region. A detailed description of the methodology used 
in the GEDA surveys 2009, 2010 and 2012 is available in 
earlier publications [13–15].
The relative diabetes-related mortality risks were calcu-
lated using the ratio of the mortality of people with docu-
mented diabetes to that of people without documented 
diabetes. Documented diabetes is defined as a confirmed 
inpatient diagnosis in at least one quarter or a confirmed 
documented outpatient diagnosis (E10 to E14) in at least 
two quarters of one year among people with statutory 
health insurance. A detailed description of the methodol-
ogy and preparation of the health care data from statutory 
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found among 80- to 84-year-olds at 22.0% in women and 
24.6% in men. Women and men aged 90 years or above 
have the highest prevalence of health impairments (33.8% 
and 32.5%).
In 2014, women with diabetes (Figure 1) aged 30 to 34 
years could expect 36.4 additional healthy life years; men 
in this age group could expect a further 32.4 healthy life 
years. Women aged 50 to 54 years could expect 20.3 healthy 
life years and men 18.7. Women aged 70 to 74 years could 
expect 9.2 healthy life years and men 8.5. People with dia-
betes can expect significantly fewer healthy life years than 
people without diabetes, and this particularly applies to 
younger and middle-aged groups (Table 1). The difference 
between the two groups is 11.2 years for women and 11.7 
years for men aged 30 to 34 years; 8.8 and 7.4 years among 
50- to 54-year-olds, and 4.3 and 3.4 years among people 
aged 70 to 74 years. Women can expect more healthy life 
years than men in all age groups, irrespective of their dia-
betes status. Among people aged 30 to 34 years, a 4.0-year 
health insurers can be found online and in an earlier pub-
lication [16, 17]. 
The estimates of healthy life years were calculated in 
three steps: first, age-specific mortality rates for people with 
and without diabetes were calculated using age-specific data 
on mortality rates among the general population, diabetes 
prevalence and diabetes-related relative mortality risks. Sec-
ond, diabetes-specific mortality rates were used to calculate 
the life expectancies of people with and without diabetes. 
Finally, the Sullivan method [18] was used to estimate healthy 
life years using data on age-specific life expectancy and the 
age-specific prevalence of health impairments.
Results and discussion
Between 2009 and 2012, the prevalence of diabetes among 
women and men aged 30 years or above was 10.4%; the 
prevalence of health impairments was 13.5% among women 
and 12.3% among men. These prevalences increase sig-
nificantly with age. The highest prevalence of diabetes is 
Figure 1 
Remaining healthy life years and life expectancy 
among women aged 30 years or above without 
and with diabetes by age group in 2014 
Source: GEDA 2009, GEDA 2010, GEDA 2012, 
Causes of Death Statistics from the Federal 
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HLY = Healthy life years, LE = Life expectancy
People who have diabetes 
can expect to have  
significantly fewer healthy 
life years than people 
without diabetes; this 
particularly applies to 
younger and middle-aged 
people.
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tality [19] and fewer healthy life years. The present study 
indicates that women and men with diabetes in Germany 
can expect significantly fewer healthy life years than those 
without diabetes, and that this finding particularly applies 
difference in healthy life years was identified between 
women and men with diabetes and 3.5 for those without 
diabetes. This difference decreases with age and is lower 
than twelve months as of 80 years-of-age.
Women aged 30 to 34 years with diabetes have a remain-
ing life expectancy of 48.0 years (Figure 1), whereas the life 
expectancy among men is 42.6 years (Figure 2). However, 
women with diabetes in this age group still have around 
twelve fewer healthy life years, and men with diabetes 
around ten fewer healthy life years than their peers without 
diabetes. Healthy life years make up 75.8% of the remain-
ing life expectancy for women with diabetes aged 30 to 34 
years and 86.7% of the remaining life expectancy for women 
without diabetes; the figures are similar for men at 76.0% 
and 87.8%. These figures decrease equally for both sexes 
with rising age, irrespective of diabetes status.
Diabetes can be associated with serious comorbidities 
and secondary diseases [2] that can result in significant 
health-related functional impairments [8], premature mor-
Figure 2 
Remaining healthy life years and life expectancy 
among men aged 30 years or above without 
and with diabetes by age group in 2014
Source: GEDA 2009, GEDA 2010, GEDA 2012, 
Causes of Death Statistics from the Federal 
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Table 1 
Difference between healthy life years for 
people without and with diabetes aged 
30 years or above
Source: GEDA 2009, GEDA 2010, GEDA 2012, 
Causes of Death Statistics from the Federal 
Statistical Office 2014, DaTraV data 2013/2014
Women Men
Age group Difference (95% CI) Difference (95% CI)
30–34 years 11.2 (10.3–12.1) 11.7 (10.6–12.9)
35–39 years 10.8 (9.9–11.7) 11.1 (10.1–12.2)
40–44 years 10.4 (9.6–11.3) 9.7 (8.9–10.5)
45–49 years 9.6 (8.8–10.4) 8.6 (7.9–9.4)
50–54 years 8.8 (8.0–9.5) 7.4 (6.7–8.0)
55–59 years 7.5 (6.8–8.2) 6.5 (5.8–7.1)
60–64 years 6.2 (5.5–6.8) 5.2 (4.6–5.7)
65–69 years 5.2 (4.6–5.8) 4.3 (3.7–4.9)
70–74 years 4.3 (3.7–4.9) 3.4 (2.9–4.0)
75–79 years 3.2 (2.6–3.9) 2.6 (2.0–3.2)
80–84 years 2.0 (1.3–2.6) 1.9 (1.2–2.6)
85–89 years 1.2 (0.5–2.0) 1.6 (0.7–2.6)
≥90 years 1.6 (0.4–2.8) 0.8 (-0.7–2.3)
CI = confidence interval
The number of healthy life 
years that people with and 
without diabetes can expect 
to have becomes similar  
with increasing age.
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diabetes than those without diabetes, and this finding par-
ticularly applies to younger and middle-aged groups. 
Women can expect more healthy life years and a longer life 
expectancy than men, regardless as to whether they have 
diabetes or not. Improvements in diabetes care will be nec-
essary in order to reduce the severity of health-related func-
tional impairments.
Within the framework of the diabetes surveillance, future 
analyses of healthy life years should also focus on identi-
fying particularly disadvantaged groups and regions so as 
to determine where effective health policy measures need 
to be put in place to reduce these differences.
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Data protection and ethics
GEDA 2009, 2010 and 2012 were approved by the Federal 
Commissioner for Data Protection and Freedom of Infor-
mation (BfDI). Verbal consent to participate was obtained 
to younger and middle-aged groups. An earlier study of 
people aged 65 years or above using relative diabetes- 
related mortality risks from the 12-year mortality follow-up 
of the German National Health Interview and Examination 
Survey 1998 (GNHIES98) in place of DaTraV data but also 
using prevalences of health impairments from the GEDA 
surveys 2009 to 2012, as is the case with the present study, 
reported similar results [19].
When discussing the results presented here in the con-
text of the literature, it should be noted that the instruments 
used for assessing health impairments and definitions of 
the construct ‘health impairment’ can differ significantly. 
This means that a direct comparison of the figures on 
healthy life years is often only possible to a limited extent. 
With respect to differences in healthy life years between 
people with and without diabetes, similar figures to those 
differences presented here have been identified by other 
studies [8, 20, 21], even though they used other instruments 
(e.g. Activities of Daily Living, ADL, and Instrumental Activ-
ities of Daily Living, iADL) and observation periods and 
different prevalences of health-related impairments. Irre-
spective of their diabetes status, women can expect to have 
a higher life expectancy as well as to have more life years 
free of health impairments than men. These differences 
between the sexes have been observed worldwide for a long 
time and are mainly explained by biological and behavioural 
factors [22]. With increasing age, the remaining length of 
time that people with or without diabetes can expect to 
remain free from health impairments becomes similar. This 
is to be expected, due to people’s limited lifespan.
In summary, the figures for healthy life years and life 
expectancy are significantly lower for women and men with 
Women can expect to have 
more healthy life years than 
men; this applies to women 
with and without diabetes.
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in older adults: results from the National Health and Nutrition  
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33(5):1055–1060
11. Lyu W, Wolinsky FD (2017) The Onset of ADL Difficulties and 
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J Public Health 13(3 Suppl):6–14
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träge zur Gesundheitsberichterstattung des Bundes. RKI, Berlin. 
https://edoc.rki.de/handle/176904/3232 (As at 26.04.2021)
14. Robert Koch-Institut (RKI) (Ed) (2012) Daten und Fakten: Ergeb-
nisse der Studie „Gesundheit in Deutschland aktuell 2010“. Bei-
träge zur Gesundheitsberichterstattung des Bundes. RKI, Berlin. 
https://edoc.rki.de/handle/176904/3237 (As at 26.04.2021)
15. Robert Koch-Institut (RKI) (Ed) (2014) Daten und Fakten: Ergeb-
nisse der Studie „Gesundheit in Deutschland aktuell 2012“. Bei-
träge zur Gesundheitsberichterstattung des Bundes. RKI, Berlin. 
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versorgungsdaten.pdf (As at 26.04.2021)
17. Schmidt C, Reitzle L, Heidemann C et al. (2021) Excess mortality 
in adults with documented diabetes in Germany: routine data 
analysis of all insurance claims in Germany 2013–2014. BMJ 
open 11(1):e041508
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from all respondents at the beginning of the telephone 
interview.
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